Pep Coll
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS Research and Interventions 12
- HIV/AIDS drug development and treatment 2
- Parvovirus B19 Infection Studies 1
- Virology 6
- HIV Research and Treatment 6
- Co-authors
- James T Pacala (1 shared paper)Michael Meulbroek (5 shared papers)Bonaventura Clotet (5 shared papers)Carlos Iniesta (2 shared papers)Asunción Díaz (2 shared papers)Elisa Martró (1 shared paper)María Jesús Barberà (1 shared paper)Gema Fernández (1 shared paper)
- Journals
- PLoS ONE (3 papers)Frontiers in Public Health (1 paper)Journal of Virus Eradication (1 paper)HIV Medicine (1 paper)Scientific Reports (1 paper)
- Partner nations
- SpainUnited KingdomUnited States
In The Last Decade
Pep Coll
16 papers receiving 148 citations
Peers
Comparison fields: 5 of 42
- Virology 37
- Infectious Diseases 76
- Microbiology 23
- Epidemiology 57
- Emergency Medicine 8
Countries citing papers authored by Pep Coll
This map shows the geographic impact of Pep Coll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pep Coll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pep Coll more than expected).
Fields of papers citing papers by Pep Coll
This network shows the impact of papers produced by Pep Coll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pep Coll. The network helps show where Pep Coll may publish in the future.
Co-authors
The 25 scholars most cited alongside Pep Coll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 26 | |
| 2 | 2018 | 25 | |
| 3 | 2020 | 20 | |
| 4 | 2021 | 16 | |
| 5 | Cytomegalovirus colitis in an older woman, successfully treated with ganciclovir. | 1992 | 13 |
| 6 | 2018 | 12 | |
| 7 | 2021 | 9 | |
| 8 | 2022 | 9 | |
| 9 | A placebo-controlled ati trial of HTI vaccines in early treated HIV infection | 2021 | 6 |
| 10 | 2000 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 4 | |
| 13 | 2020 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2019 | 1 | |
| 16 | 2015 | 1 | |
| 17 | El parlar del pallars | 1991 | 0 |
| 18 | 2022 | 0 | |
| 19 | 2025 | 0 | |
| 20 | El segle de la llum | 2014 | 0 |
About Pep Coll
Pep Coll is a scholar working on Infectious Diseases, Virology, Epidemiology, Molecular Biology and Social Psychology, having authored 20 papers that have together received 154 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (6 papers), HIV, Drug Use, Sexual Risk (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV-related health complications and treatments (1 paper), Health, Education, and Physical Culture (1 paper) and Parvovirus B19 Infection Studies (1 paper). The work is most often cited by research in Virology (37 citations), Infectious Diseases (76 citations), Microbiology (23 citations), Epidemiology (57 citations) and Emergency Medicine (8 citations). Pep Coll has collaborated with scholars based in Spain, United Kingdom and United States. Frequent co-authors include James T Pacala, Michael Meulbroek, Bonaventura Clotet, Carlos Iniesta, Asunción Díaz, Elisa Martró, María Jesús Barberà, Gema Fernández, Verónica Saludes and Tomáš Hanke. Their work appears in journals such as PLoS ONE, Frontiers in Public Health, Journal of Virus Eradication, HIV Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.